The data for the genitourinary system diseases mortality rate among women in the Netherlands forecasts a gradual increase from 20.1 per 100,000 women in 2024 to 20.3 in 2028. Comparing the earlier years with these projections, we see minimal annual variations. Specifically, there is no change between 2024 and 2025, and a slight 0.5% increase annually from 2026 onwards. The 5-year compound annual growth rate (CAGR) is projected to be around 0.25%.
Future trends to watch for include potential advancements in medical treatments and preventive measures that could influence mortality rates. Additionally, demographic shifts and healthcare policy changes in the Netherlands may also impact these future projections.
